Log in

NYSEARCA:ARKGARK Genomic Revolution Multi-Sector ETF Stock Price, Forecast & News

$44.88
-0.28 (-0.62 %)
(As of 06/5/2020 04:00 PM ET)
Add
Today's Range
$44.70
Now: $44.88
$46.41
50-Day Range
$35.05
MA: $43.18
$49.56
52-Week Range
$24.00
Now: $44.88
$51.16
Volume888,053 shs
Average Volume353,322 shs
Market Capitalization$1.04 billion
P/E RatioN/A
Dividend Yield4.67%
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.87 out of 5 stars


Basic Details

Issuer ARK
Fund NameARK Genomic Revolution Multi-Sector ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:ARKG
Inception Date10/30/2014
Fund ManagerCatherine D. Wood
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNot Applicable
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$1.04 billion
Average Daily Volume$656,479.70
Discount/Premium0.01%

ETF Expenses

Management Fee0.75%
Other Expenses0.00%
Total Expenses0.75%
Fee Waiver0.00%
Net Expenses0.75%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorARK Investment Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorForeside Fund Services, LLC
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerJane Street

Receive ARKG News and Ratings via Email

Sign-up to receive the latest news and ratings for ARKG and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG)
Currency Exposure of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG)
Sector Exposure of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG)
Industry Exposure of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG)

ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG) Frequently Asked Questions

How has ARK Genomic Revolution Multi-Sector ETF's stock been impacted by COVID-19 (Coronavirus)?

ARK Genomic Revolution Multi-Sector ETF's stock was trading at $32.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ARKG stock has increased by 39.6% and is now trading at $44.8750. View which stocks have been most impacted by Coronavirus.

How often does ARK Genomic Revolution Multi-Sector ETF pay dividends? What is the dividend yield for ARK Genomic Revolution Multi-Sector ETF?

ARK Genomic Revolution Multi-Sector ETF declared an annual dividend on Friday, December 27th. Stockholders of record on Monday, December 30th will be paid a dividend of $1.054 per share on Tuesday, December 31st. This represents a dividend yield of 3.06%. The ex-dividend date is Friday, December 27th. View ARK Genomic Revolution Multi-Sector ETF's dividend history.

Has ARK Genomic Revolution Multi-Sector ETF been receiving favorable news coverage?

Media coverage about ARKG stock has been trending somewhat positive on Sunday, according to InfoTrie. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ARK Genomic Revolution Multi-Sector ETF earned a coverage optimism score of 1.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news aboutARK Genomic Revolution Multi-Sector ETF.

What other stocks do shareholders of ARK Genomic Revolution Multi-Sector ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARK Genomic Revolution Multi-Sector ETF investors own include ARK Innovation ETF (ARKK), NVIDIA (NVDA), Johnson & Johnson (JNJ), Tesla (TSLA), AbbVie (ABBV), Alibaba Group (BABA), Micron Technology (MU), Advanced Micro Devices (AMD), Baidu (BIDU) and Canopy Growth (CGC).

What is ARK Genomic Revolution Multi-Sector ETF's stock symbol?

ARK Genomic Revolution Multi-Sector ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ARKG."

Who are ARK Genomic Revolution Multi-Sector ETF's major shareholders?

ARK Genomic Revolution Multi-Sector ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Carroll Financial Associates Inc. (2.83%), Cambridge Investment Research Advisors Inc. (0.66%), Kovack Advisors Inc. (0.13%), Janney Montgomery Scott LLC (0.07%), Integrated Wealth Concepts LLC (0.06%) and Strategic Advisors LLC (0.06%).

Which institutional investors are selling ARK Genomic Revolution Multi-Sector ETF stock?

ARKG stock was sold by a variety of institutional investors in the last quarter, including Certified Advisory Corp, and Edge Wealth Management LLC.

Which institutional investors are buying ARK Genomic Revolution Multi-Sector ETF stock?

ARKG stock was bought by a variety of institutional investors in the last quarter, including Carroll Financial Associates Inc., Bank of New York Mellon Corp, Integrated Wealth Concepts LLC, Strategic Advisors LLC, EPG Wealth Management LLC, JPMorgan Chase & Co., Cambridge Investment Research Advisors Inc., and Steward Partners Investment Advisory LLC.

How do I buy shares of ARK Genomic Revolution Multi-Sector ETF?

Shares of ARKG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ARK Genomic Revolution Multi-Sector ETF's stock price today?

One share of ARKG stock can currently be purchased for approximately $44.88.

How big of a company is ARK Genomic Revolution Multi-Sector ETF?

ARK Genomic Revolution Multi-Sector ETF has a market capitalization of $1.04 billion.

This page was last updated on 6/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.